Orthofix Medical INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Orthofix Medical Inc. reported 2025 net sales of $822.3 million, a 2.9% increase, alongside strategic discontinuation of M6 artificial disc product lines and ongoing legal proceedings involving former executives.
NASDAQ
Orthofix Medical Inc.'s 2024 10-K filing reveals a 7.1% increase in net sales, driven by growth in key segments, while navigating ongoing integration efforts and strategic realignments.
NASDAQ
Orthofix Medical Inc. released its 10-K filing, highlighting a significant increase in net sales and strategic advancements in its Global Spine and Global Orthopedics segments for the year ended December 31, 2023.